Anticoagulation and antiplatelet effects of semax under conditions of acute and chronic immobilization stress.
Grigorjeva. M E ME; Lyapina. L A LA
Key Findings
- Intranasal semax reduced hypercoagulation caused by acute and chronic immobilization stress in rats.
- The peptide stimulated components of the anticoagulation and fibrinolytic systems, indicating a protective antistress effect.
- Repeated dosing was required to see the beneficial effect under stress conditions.
Practical Outcomes
- The results suggest semax might help counter stress‑related blood clotting, but the evidence is limited to animal models and intranasal dosing. Biohackers should view this as an early, exploratory finding and not a ready‑to‑use protocol for humans. More human research is needed before recommending semax for anticoagulation or stress mitigation.
Summary
In a rat study, giving the peptide semax through the nose helped keep the blood from clotting too much when the animals were under short‑term or long‑term immobilization stress. The peptide seemed to boost the body's natural anticoagulation and fibrinolytic (clot‑breaking) systems, acting as a stress‑protective agent.
Abstract
The effects of semax on anticoagulant, fibrinolytic, and platelet components of the anticoagulation system were studied on albino rats under conditions of acute and chronic immobilization stress. Semax exhibited a protective antistress effect after repeated intranasal administration under conditions of hypercoagulation developing in response to immobilization stress of different degree. The effect manifested in stimulation of the anticoagulation system.
Study Information
pubmed
2010
2010-06-16T00:00:00.000Z
10.1007/s10517-010-0871-x
6
10